Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review
Background: Budget impact analysis (BIA) is an economic assessment that estimates the financial consequences of adopting a new intervention. BIA is used to make informed reimbursement decisions, as a supplement to cost-effectiveness analyses (CEAs).Objectives: We systematically reviewed BIA studies...
Enregistré dans:
Auteurs principaux: | Zejun Luo, Zhen Ruan, Dongning Yao, Carolina Oi Lam Ung, Yunfeng Lai, Hao Hu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a0af68f6f1624bf5ba2cdb9e929b7fb9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Handling Uncertainty in Cost-Effectiveness Analysis: Budget Impact and Risk Aversion
par: Pedram Sendi, et autres
Publié: (2021) -
Advancing the Regulation of Traditional and Complementary Medicine Products: A Comparison of Five Regulatory Systems on Traditional Medicines with a Long History of Use
par: Zuanji Liang, et autres
Publié: (2021) -
Is the Scope of Costs Considered in Budget Impact Analyses for Anticancer Drugs Rational? A Systematic Review and Comparative Study
par: Yue Ma, et autres
Publié: (2021) -
The short-term associations of chronic obstructive pulmonary disease hospitalizations with meteorological factors and air pollutants in Southwest China: a time-series study
par: Meng Li, et autres
Publié: (2021) -
CEA preoperatorio como factor pronóstico en cáncer de colon y recto: análisis de 532 pacientes
par: BANNURA C,GUILLERMO, et autres
Publié: (2008)